Sermorelin research: growth hormone releasing hormone analog
Sermorelin research explained: GHRH analog signaling, pituitary GH release, and how it compares with CJC-1295 and tesamorelin.
Growth Hormone Secretagogues
Ipamorelin selectivity: why researchers study this GHRP
Ipamorelin selectivity explained for researchers: ghrelin receptor signaling, GH release, and why it differs from older GHRPs.
CJC-1295 with and without DAC: key research differences
CJC-1295 with and without DAC explained for researchers: half-life, albumin binding, pulsatile GH release, and key study differences.
Sermorelin vs Tesamorelin: Research Comparison Guide (2026)
Research guide: Sermorelin vs Tesamorelin. Both are GHRH analogs, but one is a short active fragment and the other is a modified full-length analog with a deeper metabolic literature. By Daymion Alvarez.
Ipamorelin vs Tesamorelin: Research Comparison Guide (2026)
Research guide: Ipamorelin vs Tesamorelin. Both support growth hormone research, but one acts through the ghrelin receptor while the other is a modified GHRH analog with a distinct metabolic literature. By Daymion Alvarez.
Ipamorelin vs Sermorelin: Research Comparison Guide (2026)
Research guide: Ipamorelin vs Sermorelin. Both support growth hormone research, but one acts through the ghrelin receptor while the other mimics GHRH signaling. By Daymion Alvarez.
CJC-1295 vs Tesamorelin: Research Comparison Guide (2026)
Research guide: CJC-1295 vs Tesamorelin. Both are GHRH analogs, but one was engineered for broader GH research while the other earned FDA approval for a specific metabolic indication. By Daymion Alvarez.
CJC-1295 vs Sermorelin: Research Comparison Guide (2026)
Research guide: CJC-1295 vs Sermorelin. Both GHRH analogs, same amino acid count, very different pharmacokinetics. How they compare in published studies. By Daymion Alvarez.
CJC-1295 (No DAC) vs Ipamorelin: Research Comparison Guide (2026)
Research guide: CJC-1295 vs Ipamorelin. Two different receptor pathways, both stimulating GH release. How they compare in published studies. By Daymion Alvarez.
Tesamorelin: Complete Research Guide (2026)
Tesamorelin research guide: the FDA-approved GHRH analog, mechanism of action, lipodystrophy research, metabolic effects, and how it compares to sermorelin and CJC-1295.
Sermorelin: Complete Research Guide (2026)
Sermorelin research guide: GHRH(1-29) mechanism, pituitary function support, age-related GH decline research, and how it compares to Tesamorelin and CJC-1295.
Ipamorelin: Complete Research Guide (2026)
Ipamorelin research guide: the first selective GH secretagogue, ghrelin receptor mechanism, comparison with CJC-1295, and what the clinical research shows.
CJC-1295 (No DAC): Complete Research Guide (2026)
CJC-1295 No DAC research guide: GHRH analog mechanism, pulsatile GH release studies, comparison with Ipamorelin, and what the published research shows.